DataDiva — the market caseWhy a serious B2B social budget pays back
B2B social media has stopped being an awareness line item. The data now shows it as a measurable demand and trust engine — and on a like-for-like basis it returns more than most paid channels, because the buyer has moved there before sales ever hears from them.
Why the channel mix matters: visitor-to-lead conversion by platform
The one-sentence case for the CFO: the audience that signs off your deal already does most of its vetting on LinkedIn, the channel that both converts B2B traffic best and returns the highest measured 3-year ROI — so under-investing isn't caution, it's ceding the vetting stage to whoever does show up.
DataDiva — mechanicsWhat specifically drives the ROI — and how it has changed
The return doesn't come from "posting on the company page." It comes from four mechanics that have inverted the old B2B playbook in the last ~3 years.
| Driver | Old playbook (≤2022) | What drives ROI now (2026) |
|---|---|---|
| Voice | Brand page broadcasts polished corporate posts | Employees & executives post in their own voice — people trust people, not logos. 45% of B2B brands now use employees as influencers (Marketing Week) |
| Format | Whitepaper links, static graphics | Short-form video. 78% of B2B marketers use video; 41% say short-form delivers the highest ROI of any format (LinkedIn B2B Benchmark 2025) |
| Production | Agency-shot, stock footage, high polish | Authenticity beats polish — CEO clips shot on a phone outperform corporate edits (DoubleShot 2026) |
| Discovery | Google → website → form | Social search & AI. Buyers search LinkedIn/YouTube first; LinkedIn is now the most-cited domain in LLM answers to professional queries (Profound 2026) |
| Metric | Impressions & follower count | Engagement from target accounts & pipeline influence — depth over frequency (attention is the scarce currency) |
The cost lever that closes the business case: employee advocacy converts your own people into distribution you already pay for. Dropbox reported up to a 91% reduction in paid-media spend by leaning on employee advocacy instead of ads (DSMN8). 67% of B2B influencer/advocacy campaigns out-perform brand-only content (TopRank 2025).
DataDiva — benchmarksWho does it well, and what they use
The relevant exemplars for Roche aren't tech startups — they're large, regulated, science-led organisations that solved the same compliance problem.
| Brand | What they do well | How / tools |
|---|---|---|
| AstraZeneca | The closest analogue. Built a thriving employee-advocacy programme inside one of the most compliance-heavy sectors on earth — proving regulation isn't the blocker, ambiguity is | A "LinkedIn Academy" that trains employees ("gems") on profile, storytelling, video & AI-assisted content; a short, clear "don't" list (no product claims, no trial data, no medical advice) — case |
| Novo Nordisk | Disease-awareness & science storytelling at scale; consistent executive presence | Brand + employee channels on LinkedIn, long-form video, patient-story formats |
| Siemens Healthineers / GE HealthCare | Thought-leadership on innovation; turning engineers & clinicians into credible voices | Executive video series, LinkedIn newsletters, event-led live content |
| Novartis | Omnichannel HCP engagement — social as one orchestrated layer, not a silo | Account-based content, marketing-automation tie-in, value-based messaging |
| Pfizer | Evidence-first positioning — every claim anchored to clinical & real-world data | Data-led posts, credibility as the differentiator |
The common toolstack: LinkedIn (organic + Sales Navigator for social selling) as the spine; an employee-advocacy platform (e.g. DSMN8, EveryoneSocial, Sprout/Hootsuite Amplify) to arm staff; short-form video tooling; and an analytics layer (e.g. Supermetrics) to tie social to pipeline. Articulate note the differentiator is rarely the software — it's the editorial engine and the training, which is exactly what an agency supplies.
DataDiva — 2026 radarWhat's hot right now
Rising
- Executive & employee-led video — short, authentic, phone-shot. The single biggest reach multiplier.
- "Social search" + GEO — optimise LinkedIn/YouTube content to be found by buyers and cited by AI assistants. LinkedIn is the #1 LLM-cited professional domain.
- B2B creators & subject-matter influencers — analysts, clinicians, KOLs as third-party credibility. 53% of B2B marketers are increasing influencer budgets.
- AI as backbone — personalisation, lead scoring, content variants. Gen-AI now in 15.1% of marketing activity, +116% since 2024 (CMO Survey).
- Depth over frequency — fewer, better posts measured on target-account engagement, not impressions.
Fading
- Broadcast brand-page posting with no human face ("Social 3.0" — the death of broadcast social).
- Polished corporate video with stock footage and generic voiceover.
- Impressions / follower count as the headline KPI.
- Posting more as a strategy — volume without depth now actively backfires against finite attention.
- Treating social as a silo rather than the front of the buying journey.
SallySocials — recommended strategyThe play for a brand like Roche
Most large pharma social fails the same way: a corporate page broadcasting compliance-sanitised posts to an audience that isn't there, measured on impressions. That's the incumbent pattern — busy, polished, and invisible to the buyer. Here's what replaces it.
✗ What "doing it wrong" looks like
- Everything routed through one corporate page
- Polished posts, no human voice, no video
- Legal fear → vague, sanitised, forgettable content
- Reported on reach & followers
- Social run as a publishing calendar, disconnected from sales
✓ What the data says to do
- Activate executives & employees as the primary voices
- Short, authentic video as the default format
- Compliance as an enabler: a short, clear "don't" list + training
- Reported on target-account engagement & pipeline influence
- Social as the front door of the buying journey, wired to CRM
The five pillars
- Executive thought leadership. 2–4 senior leaders posting in their own voice, ghost-supported by an editorial engine. This is the 55%-of-decision-makers play — it's what they vet you on.
- Employee advocacy at scale. An AstraZeneca-style "academy": train a cohort of willing staff, give them a clear guardrail list, arm them with content. This is the reach multiplier and the paid-spend reducer (cf. Dropbox −91%).
- Short-form video engine. 60–90s executive insights, clinician/engineer explainers, customer/patient stories — phone-shot, authentic, repurposed across LinkedIn & YouTube.
- Social-search & AI visibility (GEO). Structure content to be found by buyers searching LinkedIn/YouTube and to be cited by AI assistants — the new top-of-funnel.
- Measurement wired to pipeline. Drop impressions as the headline. Track engagement from target accounts, SQLs influenced, and cost-per-lead vs paid — proving the ROI the market data promises.
Why this beats the incumbent on her own ground: she's optimising a channel (the brand page) the data says is the weakest link, on a metric (impressions) the market has abandoned. The strategy above moves budget to the highest-ROI mechanics — human voice, video, advocacy — and reports on the number a CFO actually cares about. Same compliance constraints; opposite result. AstraZeneca already proved it works in pharma.
SallySocials — executionA 90-day pilot to prove it
Designed to de-risk the investment: small cohort, fast proof, measurable against the incumbent baseline.
| Phase | Weeks | What happens |
|---|---|---|
| Baseline & guardrails | 1–2 | Audit current output, set the pipeline baseline, agree the short compliance "don't" list with legal/medical, pick 2–3 execs + a 10-person employee cohort |
| Academy & engine | 3–4 | Run the training (profile, voice, video basics, AI-assist); stand up the editorial engine + first content bank |
| Publish & learn | 5–10 | Executives + cohort post on cadence; weekly short-form video; measure target-account engagement, iterate on what lands |
| Prove & scale plan | 11–13 | Report pilot results vs baseline (reach, engagement-from-target-accounts, leads influenced, cost-vs-paid); recommend roll-out scope |